| 1 | 2025 ·General Hospital Psychiatry ·R Philipp,
(unknown),
Uwe Koch,
Karin Oechsle,
(unknown),
(unknown),
(unknown),
(unknown),
David W. Kissane,
Guntram Lock,
Christopher Lo,
(unknown),
Volkmar Müller,
Martin Reck,
Georgia Schilling,
Kornelius Schulze,
(unknown),
Carsten Bokemeyer,
Martin Härter,
Sigrun Vehling | 1 |
| 2 | 2025 ·American Journal of Respiratory and Critical Care Medicine ·Mustafa Abdo,
Henrik Watz,
Frederik Trinkmann,
Sabine Bohnet,
(unknown),
(unknown),
(unknown),
Martin Reck,
(unknown),
(unknown),
Sabine Dettmer,
Benjamin Waschki,
Klaus F. Rabe,
Klaas Franzen,
Jens Vogel‐Claussen | 1 |
| 3 | 2025 ·European Journal of Cancer ·(unknown),
Martin Reck,
Daniel Martín,
Stefan Rieken,
(unknown),
(unknown),
(unknown),
(unknown),
Hubert Serve,
Thomas Oellerich,
Martin Sebastian,
Friederike C. Althoff | 3 |
| 4 | 2024 ·Annals of Oncology ·(unknown),
Martin Reck,
Enriqueta Felip,
(unknown),
(unknown),
Rüediger Liersch,
Satoshi Oizumi,
Hiroshi Tanaka,
John Hamm,
Steve McCune,
(unknown),
(unknown),
(unknown),
Silvia Novello,
(unknown),
(unknown),
(unknown),
(unknown),
C.Z. Zhou | 5 |
| 5 | 2024 ·Journal of Thoracic Oncology ·Janet Gray,
Joel W. Neal,
Jyoti D. Patel,
Stephen V. Liu,
N. Girard,
Martin Reck,
(unknown),
(unknown),
(unknown),
(unknown),
Byoung Chul Cho,
(unknown),
Sabeen Mekan,
(unknown),
(unknown),
(unknown),
Michael Chisamore,
(unknown) | 3 |
| 6 | 2024 ·Annals of Oncology ·(unknown),
Mauricio Burotto,
(unknown),
Martin Reck,
(unknown),
(unknown),
(unknown),
(unknown),
(unknown),
Vamsidhar Velcheti,
(unknown),
(unknown),
(unknown),
(unknown),
Munir Chowdhury,
Thomas Spires,
(unknown),
Manuel Cobo | 10 |
| 7 | 2024 ·Journal of Clinical Oncology ·Heather A. Wakelee,
Nasser K. Altorki,
Caicun Zhou,
Tibor Csőszi,
Ihor Vynnychenko,
(unknown),
Achim Rittmeyer,
Martin Reck,
Alex Martínez‐Martí,
Hirotsugu Kenmotsu,
Yuh-Min Chen,
Antonio Chella,
Shunichi Sugawara,
Chenqi Fu,
Marcus Ballinger,
Yu Deng,
Minu K. Srivastava,
Elizabeth Bennett,
(unknown),
Enriqueta Felip | 6 |
| 8 | 2023 ·Journal of Thoracic Oncology ·Byoung Chul Cho,
(unknown),
Rubén Cabanillas,
David Vicente Baz,
(unknown),
Salvatore Grisanti,
(unknown),
(unknown),
(unknown),
Sabeen Mekan,
(unknown),
(unknown),
Michael Chisamore,
Martin Reck | 6 |
| 9 | | 1 |
| 10 | 2023 ·Tumor Biology ·(unknown),
Wei Zou,
Vinzent Rolny,
Martin Reck,
(unknown),
Katja Schulze,
Stefan Holdenrieder,
Mark A. Socinski,
David S. Shames,
(unknown),
Namrata S. Patil | 2 |
| 11 | 2023 ·Genes Chromosomes and Cancer ·Petros Christopoulos,
Richard F. Schlenk,
Daniel Kazdal,
(unknown),
Jochen K. Lennerz,
Rajiv Shah,
Jan Budczies,
Nisar P. Malek,
Stefan Fröhling,
Richard Rosenquist,
Peter Schirmacher,
Farastuk Bozorgmehr,
Jonas Kuon,
Martin Reck,
Michael Thomas,
Albrecht Stenzinger | 9 |
| 12 | 2023 ·Annals of Oncology ·Luis Paz‐Ares,
M-J. Ahn,
Enriqueta Felip,
Sabin Handzhiev,
(unknown),
Hiroki Izumi,
Kadoaki Ohashi,
M. Majem Tarruella,
Jennifer Moriatis Wolf,
Martin Reck,
(unknown),
Fiona Blackhall,
Anne‐Marie C. Dingemans,
Taofeek K. Owonikoko,
Suresh S. Ramalingam,
Jacob Sands,
Tony Jiang,
Sujoy Mukherjee,
Ewan M. Anderson,
Byoung Chul Cho | 1 |
| 13 | 2022 ·Journal for ImmunoTherapy of Cancer ·Yoon‐Koo Kang,
Martin Reck,
Paul Nghiem,
Feng Yan,
Gregory E. Plautz,
Hye Ryun Kim,
Taofeek K. Owonikoko,
Narikazu Boku,
Li‐Tzong Chen,
Ming Lei,
Han Chang,
Wen Lin,
Amit Roy,
Akintunde Bello,
Jennifer Sheng | 10 |
| 14 | Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133) breakdown →2021 ·Journal of Clinical Oncology ·Stephen V. Liu,
Martin Reck,
Aaron S. Mansfield,
Tony Mok,
Arnaud Scherpereel,
Niels Reinmuth,
Marina Chiara Garassino,
Javier de Castro,
Raffaele Califano,
Makoto Nishio,
Francesco Orlandi,
Jorge Alatorre-Alexander,
Ticiana Leal,
Ying Cheng,
Jong Seok Lee,
Sivuonthanh Lam,
Mark L. McCleland,
Yu Deng,
See Phan,
Leora Horn | 484 |
| 15 | Pembrolizumab Plus Ipilimumab or Placebo for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50%: Randomized, Double-Blind Phase III KEYNOTE-598 Study breakdown →2021 ·Journal of Clinical Oncology ·Michael Boyer,
Mehmet Alı Nahıt Şendur,
Delvys Rodríguez‐Abreu,
Keunchil Park,
Dae Ho Lee,
İrfan Çiçin,
Perran Fulden Yumuk,
Francesco Orlandi,
Ticiana Leal,
Olivier Molinier,
Nopadol Soparattanapaisarn,
Adrian Langleben,
Raffaele Califano,
Balazs Medgyasszay,
Te‐Chun Hsia,
Gregory A. Otterson,
Lu Xu,
Bilal Piperdi,
Ayman Samkari,
Martin Reck,
(unknown) | 165 |
| 16 | 2021 ·Journal for ImmunoTherapy of Cancer ·David R. Gandara,
Martin Reck,
Denis Moro‐Sibilot,
Julien Mazières,
Shirish M. Gadgeel,
Stefanie Morris,
Andrés F. Cardona,
Diana Mendus,
Marcus Ballinger,
Achim Rittmeyer,
Solange Peters | 14 |
| 17 | 2019 ·Molecular Case Studies ·Steffen Dietz,
Petros Christopoulos,
Lisa Gu,
Anna‐Lena Volckmar,
Volker Endris,
Zhao Yuan,
(unknown),
Tomasz Żemojtel,
Claus Peter Heußel,
Marc A. Schneider,
Michael Meister,
Thomas Muley,
Martin Reck,
Matthias Schlesner,
Michael Thomas,
Albrecht Stenzinger,
Holger Sültmann | 17 |
| 18 | | 5 |
| 19 | Phase III Randomized Trial of Ipilimumab Plus Etoposide and Platinum Versus Placebo Plus Etoposide and Platinum in Extensive-Stage Small-Cell Lung Cancer breakdown →2016 ·Journal of Clinical Oncology ·Martin Reck,
Alexander Luft,
Aleksandra Szczęsna,
Libor Havel,
Sang-We Kim,
Wallace Akerley,
M. Catherine Pietanza,
Yi‐Long Wu,
Christoph Zielinski,
Michael J. Thomas,
Enriqueta Felip,
Kathryn A. Gold,
Leora Horn,
Joachim G.J.V. Aerts,
Kazuhiko Nakagawa,
Paul Lorigan,
Anne Pieters,
(unknown),
Justin Fairchild,
David R. Spigel | 397 |
| 20 | 2016 ·Cancer Research ·Sebastian Marwitz,
Sofia Depner,
(unknown),
(unknown),
(unknown),
Karin Müller‐Decker,
Philippe Lucarelli,
(unknown),
Heimo Mairbäurl,
Klaus F. Rabe,
Christian Kügler,
Ekkehard Vollmer,
Martin Reck,
(unknown),
(unknown),
Ole Ammerpohl,
Reiner Siebert,
Torsten Goldmann,
Ursula Klingmüller | 76 |